Plancorp LLC purchased a new position in Cardinal Health Inc (NYSE:CAH) during the 4th quarter, HoldingsChannel.com reports. The firm purchased 5,115 shares of the company’s stock, valued at approximately $313,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in CAH. Ameriprise Financial Inc. lifted its holdings in shares of Cardinal Health by 38.6% in the 3rd quarter. Ameriprise Financial Inc. now owns 4,930,457 shares of the company’s stock worth $329,964,000 after purchasing an additional 1,373,334 shares during the last quarter. American Century Companies Inc. lifted its holdings in shares of Cardinal Health by 58.7% in the 3rd quarter. American Century Companies Inc. now owns 2,976,776 shares of the company’s stock worth $199,206,000 after purchasing an additional 1,100,507 shares during the last quarter. HealthCor Management L.P. bought a new stake in shares of Cardinal Health in the 2nd quarter worth approximately $84,496,000. Pzena Investment Management LLC lifted its holdings in shares of Cardinal Health by 70.6% in the 3rd quarter. Pzena Investment Management LLC now owns 1,806,522 shares of the company’s stock worth $120,892,000 after purchasing an additional 747,718 shares during the last quarter. Finally, Boston Partners lifted its holdings in shares of Cardinal Health by 31.0% in the 3rd quarter. Boston Partners now owns 2,918,367 shares of the company’s stock worth $195,297,000 after purchasing an additional 690,827 shares during the last quarter. 88.36% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Inc (NYSE:CAH) traded up $0.21 on Friday, hitting $71.91. The stock had a trading volume of 2,870,000 shares, compared to its average volume of 3,200,000. Cardinal Health Inc has a 12 month low of $54.66 and a 12 month high of $84.88. The company has a quick ratio of 0.52, a current ratio of 1.06 and a debt-to-equity ratio of 1.35. The company has a market cap of $22,670.00, a P/E ratio of 20.97, a PEG ratio of 1.67 and a beta of 0.85.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Monday, November 6th. The company reported $1.09 EPS for the quarter, topping the Zacks’ consensus estimate of $1.00 by $0.09. Cardinal Health had a return on equity of 25.24% and a net margin of 0.84%. The company had revenue of $32.64 billion for the quarter, compared to the consensus estimate of $33.48 billion. During the same quarter in the previous year, the business earned $1.24 EPS. The company’s quarterly revenue was up 1.9% compared to the same quarter last year. research analysts expect that Cardinal Health Inc will post 5.12 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Monday, January 15th. Stockholders of record on Tuesday, January 2nd were paid a $0.4624 dividend. This represents a $1.85 dividend on an annualized basis and a dividend yield of 2.57%. The ex-dividend date of this dividend was Friday, December 29th. Cardinal Health’s dividend payout ratio is presently 53.94%.

Several analysts have weighed in on CAH shares. Robert W. Baird reaffirmed a “hold” rating and set a $80.00 target price on shares of Cardinal Health in a research note on Wednesday. Evercore ISI started coverage on Cardinal Health in a research note on Thursday, January 4th. They set an “in-line” rating and a $67.00 target price on the stock. ValuEngine downgraded Cardinal Health from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. Deutsche Bank started coverage on Cardinal Health in a research note on Monday, December 4th. They set a “hold” rating and a $64.00 target price on the stock. Finally, Morgan Stanley downgraded Cardinal Health from an “equal weight” rating to an “underweight” rating in a research note on Monday, November 20th. Two analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and four have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $73.58.

TRADEMARK VIOLATION NOTICE: “Plancorp LLC Purchases New Holdings in Cardinal Health Inc (CAH)” was originally posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this piece on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The original version of this piece can be accessed at https://theolympiareport.com/2018/01/19/plancorp-llc-purchases-new-holdings-in-cardinal-health-inc-cah.html.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health Inc (NYSE:CAH).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.